July 4, 2014 / 6:41 AM / 3 years ago

China approves Bayer deal to buy Dihon, other deals

SHANGHAI, July 4 (Reuters) - The Chinese Ministry of Commerce’s anti-monopoly bureau has approved German drugmaker Bayer AG’s deal for traditional Chinese medicine (TCM) drugmaker Dihon Pharmaceutical Group Co, in a raft of deals approved on Friday.

China also approved a joint venture deal between China Huiyuan Juice Group Ltd and Suntory (Shanghai) Foods Co Ltd, a subsidiary of Japan’s Suntory Holdings Ltd. (Reporting by Adam Jourdan)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below